On this week’s Tech Nation, we remember Paul Ehrlich, Bing Professor of Population Studies and Professor of Biology at Stanford University. With his recent passing, we’re revisiting our 2008 interview where he discusses his new book, “The Dominant Animal”, as well as his seminal 1968 book, “The Population Bomb”. Then, Dan Schmitt of Actuate Therapeutics tells us about a new drug showing positive early results in adult pancreatic cancer, and two pediatric cancers.

On this week’s Tech Nation, you are smarter than you know - Dr. Angus Fletcher talks about “Primal Intelligence”... then Dr. Derek Jantz from Tune Therapeutics explains how they aim to "tune" DNA - not just with human DNA, but stopping the Hepatitis B virus in its tracks.

On this week’s Tech Nation, Moira speaks with Dr. Adam Rogers of NervGen Pharma about a new treatment in development that’s seeing significant trial results for patients with spinal cord injuries. Then, does that look on your pet’s face mean what you think it means? Jay Ingram joins Moira to talk about “The Science of Pets” and what it has to do with humans.

On this week’s BioTech Nation, Moira speaks with Dr. Adam Rogers, CEO of NervGen Pharma, about a new treatment that’s showing significant trial results for patients with spinal cord injuries. While typically, patient progress is defined by the early months of recovery after the injury, trial participants are seeing increased function as much as 10 years post-trauma.